ArticleBiomimetics (Basel, Switzerland)2025
Bio-Membrane-Based Nanofiber Scaffolds: Targeted and Controlled Carriers for Drug Delivery-An Experimental In Vivo Study.
Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Cell population and vascular vessel distribution analysis in membrane-based scaffolds for tissue engineering is crucial. Biomimetic nanostructured membranes of methyl methacrylate/hydroxyethyl methacrylate and methyl acrylate/hydroxyethyl acrylate (MMA)1-co-(HEMA)1/(MA)3-co-(HEA)2 loaded with 5% wt SiO2-nanoparticles (Si-M) were doped with zinc (Zn-M) or doxycycline (Dox-M). Critical bone defects were effectuated on six New Zealand-bred rabbit skulls and then they were covered with the membrane-based scaffolds. After six weeks, bone cell population in terms of osteoblasts, osteoclasts, osteocytes, fibroblasts, and M1 and M2 macrophages and vasculature was determined. The areas of interest were the space above (over) and below (under) the membrane, apart from the interior (inner) compartment. All membranes showed that vasculature and most cell types were more abundant under the membrane than in the inner or above regions. Quantitatively, osteoblast density increased by approximately 35% in Zn-M and 25% in Si-M compared with Dox-M. Osteoclast counts decreased by about 78% in Dox-M, indicating strong inhibition of bone resorption. Vascular structures were nearly twofold more frequent under the membranes, particularly in Si-M, while fibroblast presence remained moderate and evenly distributed. The M1/M2 macrophage ratio was higher in Zn-M, reflecting a transient pro-inflammatory state, whereas Dox-M favored an anti-inflammatory, pro-regenerative profile. These results indicate that the biomimetic electrospun membranes functioned as architectural templates that provided favorable microenvironments for cell colonization, angiogenesis, and early bone regeneration in a preclinical in vivo model. Zn-M membranes appear suitable for early osteogenic stimulation, while Dox-M membranes may be advantageous in clinical contexts requiring modulation of inflammation and osteoclastic activity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.